FDLI SmartBrief Latest Industry News

Latest News

UPDATE 1-Cephalon delays Ception deal after mixed drug data

Reuters | 5 hours 49 minutes ago

BOSTON, Nov 23 (Reuters) - Cephalon Inc (CEPH.O) said on Monday that an experimental drug for a rare type of inflammation of the esophagus showed mixed results in a mid-to-late stage clinical trial, sending its shares down more than 9 percent.... (more)

Spray can prevent premature ejaculation: study

Yahoo! | 5 hours 50 minutes ago

WASHINGTON (Reuters) ? A spray that numbs the penis can help prevent premature ejaculation, doctors reported on Thursday, and drug maker Sciele Pharma Inc, a division of Japan's Shionogi, plans to file for U.S. approval next year.... (more)

Mixed results from Ception, Cephalon on Cinquil

American City Business Journals | 5 hours 52 minutes ago

Ception Therapeutics Inc. and Cephalon Inc. announced mixed results Monday for late-stage testing of Cinquil, an experimental drug the two suburban Philadelphia biotechnology companies are developing to treat pediatric eosinophilic esophagitis.... (more)

Merck Claims Win in Texas Lawsuit Over Vioxx

ABC News | 5 hours 52 minutes ago

Merck claims win as Texas court dismisses Medicaid lawsuit over painkiller Vioxx... (more)

Boston Scientific to leave Doral

American City Business Journals | 5 hours 52 minutes ago

Medical products company Boston Scientific Corp., which has more than 1,200 employees working out of a 14-acre plant in Doral, is relocating its operation to Costa Rica over the next three years.... (more)

Astex Therapeutics gains orphan approval in US and Europe

Business Weekly (U.K.) | 6 hours 55 minutes ago

Astex Therapeutics, fresh from a multi-million pound deal with GSK, has announced that it has been granted orphan drug designation in Europe and the US for its treatment of patients with Acute Myeloid Leukaemia (AML).... (more)

UPDATE 1-Spectrum inks deal with Korea's Handok for cancer drug

Reuters | 6 hours 55 minutes ago

Nov 23 (Reuters) - Spectrum Pharmaceuticals Inc (SPPI.O) said Handok Pharmaceuticals Co Ltd (002390.KS) will develop and commercialize Spectrum's experimental cancer drug in South Korea as part of a deal valued at more than $19 million.... (more)

Frontage Expands Management Team

Bioresearch Online | 7 hours 41 minutes ago

Frontage, a leading high quality provider of drug development services and preclinical, bioanalytical, analytical, and formulation services to the global biopharmaceutical industry, announces the hire of two key leadership positions and an expansion to the business development team.... (more)

Vaccines on horizon for AIDS, Alzheimer's, herpes

Yahoo! | 7 hours 43 minutes ago

MARIETTA, Pa. ? Malaria. Tuberculosis. Alzheimer's disease. AIDS. Pandemic flu. Genital herpes. Urinary tract infections. Grass allergies. Traveler's diarrhea. You name it, the pharmaceutical industry is working on a vaccine to prevent it.... (more)

Germany's Merck will expand R&D in China

CNBC | 7 hours 44 minutes ago

FRANKFURT - German drugmaker Merck KGaA said Monday the company plans to invest euro150 million ($225 million) in a global research and development center in Beijing for its Serono drugs division.... (more)

Pill-popping approach to female libido

Guardian (London), The | 7 hours 51 minutes ago

Flibanserin's makers promise help for 'hypoactive sexual desire disorder'. It suits drug companies to medicalise in this way... (more)

< Prev ... 2 3 4 5 6 7 8 9 10 ... Next >

340 Stories | RSS Feed

Sign up for FDLI SmartBrief

Designed specifically for professionals involved in the food and drug industry, FDLI SmartBrief is a FREE daily e-mail newsletter. It provides the latest need-to-know news and industry information that maximizes your time, giving you an edge over your competition. Learn more